Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens
- PMID: 3607768
Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens
Abstract
We have examined the effect of short-term and long-term growth in the absence of estrogens on the proliferation rate and estrogen and antiestrogen responsiveness of MCF-7 human breast cancer cells. The removal of phenol red, the pH indicator in tissue culture medium that is weakly estrogenic (Y. Berthois et al., Proc. Natl. Acad. Sci. USA, 83:2496-2500, 1986), immediately slows the cell proliferation rate, and MCF-7 cells grown in phenol red-free medium with charcoal dextran-treated serum for periods up to 1 mo maintain this reduced rate of cell proliferation. In these short-term phenol red-withdrawn cells, estradiol stimulates proliferation markedly and reproducibly, and antiestrogens inhibit estrogen-stimulated proliferation. Antiestrogens by themselves appear as partial agonists/antagonists; at low concentrations they stimulate proliferation weakly, but they show no stimulation at the high concentrations where they fully inhibit estrogen-stimulated proliferation. In contrast to the short-term phenol red-withdrawn cells, cells maintained for several months (5 to 6 mo) in the apparently complete absence of estrogens (no phenol red, with charcoal dextran-treated calf serum) show a markedly increased basal rate of cell proliferation; estradiol is unable to increase this rate of proliferation further, but antiestrogens are able to decrease proliferation. This change in growth pattern is associated with a 3-fold increase in cellular estrogen receptor levels. Despite their differing basal growth rates, cells grown in either the short-term (less than 1 mo) or long-term (greater than 6 mo) absence of estrogens both have progesterone receptor levels that are very low and, in both cases, estradiol increases progesterone receptor levels markedly. Thus, under long-term estrogen-free conditions, there is a dissociation between the stimulation of cell proliferation and of specific protein synthesis (progesterone receptor) by estrogen. The increase in the cell proliferation rate observed in cells grown in the long-term absence of estrogen may reflect altered regulation of growth factor production or altered sensitivity to growth factors in the medium or produced by the cells themselves. Hence, these breast cancer cells adapt significantly to long-term growth in estrogen-free conditions, an observation that may be relevant to understanding the growth of hormone-responsive human breast cancers in vivo.
Similar articles
-
Growth factor-like activity of phenol red preparations in the MCF-7 breast cancer cell line.Anticancer Res. 1992 May-Jun;12(3):789-94. Anticancer Res. 1992. PMID: 1622138
-
Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.Cancer Res. 1994 Nov 15;54(22):5867-74. Cancer Res. 1994. PMID: 7954416
-
Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.Cancer Res. 1986 Mar;46(3):1124-31. Cancer Res. 1986. PMID: 3943090
-
Estrogen regulation of proliferation and hormonal modulation of estrogen and progesterone receptor biosynthesis and degradation in target cells.Prog Clin Biol Res. 1990;322:201-11. Prog Clin Biol Res. 1990. PMID: 2406733 Review. No abstract available.
-
Nonsteroidal antiestrogens are estrogen-receptor-targeted growth inhibitors that can act in the absence of estrogens.Horm Res. 1987;28(2-4):196-201. doi: 10.1159/000180944. Horm Res. 1987. PMID: 3331372 Review.
Cited by
-
Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.Breast Cancer Res. 2006;8(1):R2. doi: 10.1186/bcr1363. Epub 2005 Dec 12. Breast Cancer Res. 2006. PMID: 16417650 Free PMC article.
-
Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.In Vitro Cell Dev Biol Anim. 2000 Jul-Aug;36(7):428-46. doi: 10.1290/1071-2690(2000)036<0428:EMAINR>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2000. PMID: 11039494
-
Estrogen mitogenic action. III. is phenol red a "red herring"?In Vitro Cell Dev Biol Anim. 2000 Jul-Aug;36(7):447-64. doi: 10.1290/1071-2690(2000)036<0447:EMAIIP>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2000. PMID: 11039495
-
Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells.Mol Cell Biol. 2010 Feb;30(3):857-70. doi: 10.1128/MCB.00824-09. Epub 2009 Nov 23. Mol Cell Biol. 2010. PMID: 19933843 Free PMC article.
-
Avoiding the bad and enhancing the good of soy supplements in breast cancer.J Natl Cancer Inst. 2014 Sep 4;106(9):dju233. doi: 10.1093/jnci/dju233. Print 2014 Sep. J Natl Cancer Inst. 2014. PMID: 25190729 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials